• Forum
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Morning ReviewDaily market recap and key overnight highlights
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • PortfolioInderes model portfolio
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Q&A
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

Regulatory press release

HBC: Notification of major shareholdings

Hofseth BioCare
Effective February 9, 2026, the "Bonafide Investment Fund - Best Catches I" made
a subscription in kind to the "Bonafide Investment Fund - HBC II". Following the
subscription in kind, the Bonafide Investment Fund - Best Catches I no longer
holds shares in Hofseth Biocare ASA.

According to the information published on the website of the Oslo Stock
Exchange, the total number of outstanding shares of Hofseth Biocare ASA
currently amounts to 395,081,030.
Based on this figure, IFM Independent Fund Management AG will hold a total of
16.62% of the voting rights in Hofseth Biocare ASA as of February 9, 2026.

Please find attached the ESMA standard form for the notification of major
holdings.